Pages that link to "Q46054421"

The following pages link to Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. (Q46054421):

Displaying 22 items.

• Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis (Q26775340) (← links)
• Dietary habits and behaviors associated with nonalcoholic fatty liver disease (Q26830863) (← links)
• Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease. (Q33597839) (← links)
• NPC1L1 inhibitor ezetimibe is a reliable therapeutic agent for non-obese patients with nonalcoholic fatty liver disease (Q33761680) (← links)
• Glycine N-Methyltransferase Deficiency Affects Niemann-Pick Type C2 Protein Stability and Regulates Hepatic Cholesterol Homeostasis (Q34241720) (← links)
• Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease (Q34834198) (← links)
• Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol (Q35895832) (← links)
• Metabolic disorders and steatosis in patients with chronic hepatitis C: metabolic strategies for antiviral treatments (Q36026554) (← links)
• Fatty liver in men is associated with high serum levels of small, dense low-density lipoprotein cholesterol (Q36278478) (← links)
• Nutrition therapy for liver diseases based on the status of nutritional intake (Q36417913) (← links)
• The association of NR1H3 gene with lipid deposition in the pig. (Q36937104) (← links)
• Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Hugan Qingzhi and Its Protective Properties against Free Fatty Acid-Induced L02 Hepatocyte Injury (Q37670520) (← links)
• Lysosomal-specific cholesterol reduction by biocleavable polyrotaxanes for ameliorating Niemann-Pick type C disease. (Q38256378) (← links)
• Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability (Q38293474) (← links)
• Management of NAFLD: a stage-based approach (Q38747405) (← links)
• Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications (Q41706829) (← links)
• Dysregulated bile acid synthesis, metabolism and excretion in a high fat-cholesterol diet-induced fibrotic steatohepatitis in rats. (Q41773496) (← links)
• Are dietary cholesterol intake and serum cholesterol levels related to nonalcoholic Fatty liver disease in obese children? (Q41810372) (← links)
• Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation (Q42806308) (← links)
• Is the control of dietary cholesterol intake sufficiently effective to ameliorate nonalcoholic fatty liver disease? (Q42910995) (← links)
• Increased serum liver X receptor ligand oxysterols in patients with non-alcoholic fatty liver disease. (Q47791527) (← links)
• Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease (Q89220189) (← links)